Access count of this item: 170

Files in This Item:
File Description SizeFormat 
nmc.ra.2015-0303.pdf451.27 kBAdobe PDFView/Open
Title: Cell therapy for Parkinson’s disease
Authors: Morizane, Asuka  kyouindb  KAKEN_id
Takahashi, Jun
Author's alias: 森實, 飛鳥
髙橋, 淳
Keywords: Parkinson
dopamine
induced pluripotent stem cell
midbrain
Issue Date: Mar-2016
Publisher: Japan Neurosurgical Society
Journal title: Neurologia Medico-Chirurgica
Volume: 56
Issue: 3
Start page: 102
End page: 109
Abstract: In Parkinson’s disease (PD), dopamine neurons in the substantia nigra are degenerated and lost. Cell therapy for PD replaces the lost dopamine neurons by transplanting donor dopamine neural progenitor cells. Cell therapy for PD has been performed in the clinic since the 1980s and uses donor cells from the mesencephalon of aborted embryos. Regenerative medicine for PD using induced pluripotent stem (iPS) cell technology is drawing attention, because it offers a limitless and more advantageous source of donor cells than aborted embryos.
Rights: This article is applied Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY-NC-ND) by the publisher.
URI: http://hdl.handle.net/2433/226824
DOI(Published Version): 10.2176/nmc.ra.2015-0303
PubMed ID: 26912295
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.